Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.45 |
| ▸ | MEN1 | O00255 | 4/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.45 |
| ▸ | RELA | Q04206 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | AGTR1 | P30556 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6565198 | 0.80 | ALDH1A1 (0.60) | MEN1KMT2AKDM4ECYP2C19CYP3A4 | |
| SCHEMBL3364494 | 0.77 | MEN1 (0.65) | MEN1KMT2AKDM4ECYP2C19CYP3A4 | |
| SCHEMBL13750522 | 0.72 | ALDH1A1 (0.63) | MEN1KMT2AKDM4ECYP2C19HTT | |
| SCHEMBL2398445 | 0.70 | ESR2 (0.62) | MEN1KMT2AKDM4ECYP2C19CYP3A4 | |
| SCHEMBL28180041 | 0.70 | ESR2 (0.62) | MEN1KMT2AKDM4ECYP2C19CYP3A4 | |
| SCHEMBL17485808 | 0.69 | XDH (0.62) | SMN1; SMN2MEN1KMT2AKDM4ECYP2C19 | |
| SCHEMBL3368230 | 0.69 | CYP19A1 (0.59) | MEN1KMT2ACYP3A4POLBALDH1A1 | |
| SCHEMBL28545861 | 0.69 | ALDH1A1 (0.78) | SMN1; SMN2MEN1KMT2AKDM4ECYP2C19 | |
| SCHEMBL28024600 | 0.68 | ALDH1A1 (0.78) | MEN1KMT2AKDM4ECYP2C19CYP3A4 | |
| SCHEMBL13111972 | 0.67 | PDPK1 (0.51) | MEN1KMT2AKDM4ECYP2C19CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220281903-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2022-09-08 | — | — | US | claimed |
| EP-4017585-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | Mühlbauer Technology GmbH (DE) | 2022-06-29 | — | — | EP | claimed |
| WO-2021032844-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2021-02-25 | — | — | WO | claimed |
| US-20040057908-A1 | Oral compositions and use thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2004-03-25 | — | — | US | claimed |
| EP-1399119-A2 | ORAL COMPOSITIONS AND USE THEREOF | University of Rochester (US) | 2004-03-24 | — | — | EP | claimed |
| WO-2002047615-A2 | ORAL COMPOSITIONS AND USE THEREOF | UNIVERSITY OF ROCHESTER (US) | 2002-06-20 | — | — | WO | claimed |
| US-12590111-B2 | Flavonoid derivative for treating dental caries | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2026-03-31 | — | — | US | disclosed |
| US-20220281903-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2022-09-08 | — | — | US | disclosed |
| EP-4017585-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | Mühlbauer Technology GmbH (DE) | 2022-06-29 | — | — | EP | disclosed |
| WO-2021032844-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | MÜHLBAUER TECHNOLOGY GMBH (DE) | 2021-02-25 | — | — | WO | disclosed |
| US-20040057908-A1 | Oral compositions and use thereof | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2004-03-25 | — | — | US | disclosed |
| EP-1399119-A2 | ORAL COMPOSITIONS AND USE THEREOF | University of Rochester (US) | 2004-03-24 | — | — | EP | disclosed |
| WO-2002047615-A2 | ORAL COMPOSITIONS AND USE THEREOF | UNIVERSITY OF ROCHESTER (US) | 2002-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220281903-A1 | FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES | ITGA8, ITGAL, ITGB2 | SMN1; SMN2 4759/4885MEN1 4511/4885KMT2A 562/4885 |
| US-12590111-B2 | Flavonoid derivative for treating dental caries | ITGA8, ICAM1, ITGA2 | SMN1; SMN2 4851/4885MEN1 4877/4885KMT2A 879/4885 |
| US-20040057908-A1 | Oral compositions and use thereof | UGGT1, DPM1, B4GALT1 | SMN1; SMN2 4875/4885MEN1 4615/4885KMT2A 2378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.